|| Print ||
|Friday, June 18, 2010|
The Oregon Board of Pharmacy announced Thursday that it would remove marijuana from the list of “Schedule I Controlled Substances” to a schedule II classification – meaning the board recognizes that marijuana does have an acceptable medical use. Oregon is the first state in the nation to take such a step, contradicting the federal government's stance on marijuana. But advocates still are disappointed and plan to appeal.
“The classification itself shows that medical marijuana patients are still being discriminated against because [marijuana] is still classified with substances like oxycodone, which is one very small step from heroin,” said attorney Gregory Barton, who plans to appeal the decision. “[Schedule II] drugs have caused deaths whereas marijuana is basically a non-toxic herb that hasn’t ever caused any deaths.”
The reclassification comes after Senate Bill 728 passed last year, which required marijuana to be removed from the schedule I list and reclassified. Over the last several months the board listened to testimony and research from advocates and law enforcement officers concerned about abuse before voting on the reclassification.
The federal government treats marijuana as a non-medicinal Schedule I drug, but more than a dozen states including Oregon allow medical marijuana use. In addition, the regulators in the United Kingdom have approved the first-ever prescription medication derived from the cannabis plant, an MS drug called Sativex. The medication went on sale for the first time today in England.
Schedule I drugs, such as LSD and heroin, typically have no medicinal value and high abuse potential. Marijuana was moved into the schedule II substances, which are said to have “high abuse potential with severe psychological or physical dependence liability but are accepted for medical use in the US and are available by prescription,” according to the press release.
Barton is filing the appeal on the basis that the board didn’t consider the proper factors in its decision making process. “They really ended up ignoring a lot of the scientific evidence and eventually just listened to the political pressures to make it a schedule II.”
Christine McGarvin is a medical marijuana advocate who testified several months ago about the reclassification, and like many other supporters she is disgruntled by the decision.
“We don’t think medical marijuana should be classified any higher than a schedule III at least” said McGarvin. “There is a big difference between schedule II and schedule III in terms of a felony or misdemeanor according to the law.”
For a schedule II classification anyone who is not in compliance with the Oregon Medical Marijuana Act (OMMA), and possesses more than an once is immediately charged with a felony. Possessing less than an ounce of marijuana is treated as a minor violation similar to a traffic ticket under state law.
Both McGarvin and Barton cited discrepancies about where Marinol and marijuana are classified. Marinol is a purified form of THC and it’s a pharmaceutical product, but it's a schedule III classification. Marinol is already widely available through prescription. According to Barton a less purified form of a substance and the pure form is almost always scheduled in either the same or lower classification, and marijuana and Marinol are the only exceptions. He argues marijuana should at least be scheduled with Marinol, a synthetic form of THC, in the schedule III classification or lower.
This new classification won’t change anything for Initiative 28, which would allow nonprofit dispensaries to sell medical marijuana to patients and enable licensed growers to sell to dispensaries. I-28 already has accumulated an estimated 115,000 signatures, and will likely make it to the November ballot ballot.
Anthony Johnson, chief petitioner for the initiative, said the reclassification doesn’t change anything as a practical matter because the medical marijuana dispensaries would be regulated by the Department of Human Services and not the Oregon Board of Pharmacy.
“As a symbolic victory it does establish the fact that cannabis has a medicinal value and so it may help convince people that sick and disabled patients should have that option and that will convince more people to support the initiative,” said Johnson.
So the controversy continues. Read more about how pot could and already does bring economic development to Oregon as Ben Jacklet reports in “Marijuana Goes Mainstream” from the May 2010 issue of Oregon Business Magazine.
Jessica Hoch is an online reporter for Oregon Business.
Thursday, May 29, 2014
BY JON BELL
A new generation of outdoor apparel companies targets the young and the urban.
Friday, June 06, 2014
BY KATIE AUSBURGER | OB GUEST CONTRIBUTOR
How to build a hipster-friendly work environment.
Thursday, June 12, 2014
BY ANDREA DURBIN | OB GUEST BLOGGER
Last week, the Obama administration took an important and welcomed step in the effort to protect the health and well-being of all Oregonians by limiting carbon pollution from existing power plants.
Thursday, May 29, 2014
BY LINDA BAKER
Remember mood rings? A team of scientists at Oregon State University has designed what might be considered a 21st-century analog of the ’70s jewelry fad: a bracelet that reveals one’s exposure to pollutants.
Thursday, May 29, 2014
BY JONATHAN FROCHTZWAJG
For Far West Fibers, one of Oregon's largest and oldest mixed-recycling companies, garbage alchemy has long been big business.
Tuesday, July 08, 2014
BY LINDA BAKER | OB EDITOR
The New Yorker recently published a sharply worded critique of “disruptive innovation,” one of the most widely cited theories in the business world today. The article raises questions about the descriptive value of disruption and innovation — whether the terms are mere buzzwords or actually explain today's extraordinarily complex fast changing business environment.
Update: We checked in with Portland's Thomas Thurston, who offers his data driven take on the disruption controversy.
Friday, June 13, 2014
BY CLIFF HOCKLEY | OB GUEST BLOGGER
This article summarizes the key considerations a building owner must keep in mind when thinking about leasing to a medical marijuana dispensary.
|The Private 150: Bigger But Leaner|
|The Perfect Food|
|Powerlist: Staffing Firms|
|Taxis Uber Alles?|
|Comcast profit rises 15%|
|American fast food chains snagged by food safety scandal in China|
|Washington volcanoes receive more scientific scrutiny|
|Edward Snowden: Racy photos often shared at NSA|
|Forbes Media to sell majority stake|
|FedEx indicted for delivering illegal prescription drugs|
|Microsoft to cut 18,000 jobs|
Vigilant enters a New Year with a new president.
How George Fox has become one of Oregon's largest private universities.
Forest Grove sees growth in the burgeoning food and beverage scene.
Geffen Mesher is saddened to announce the passing of long-time shareholder, Tom “Mike” Anderson, who died on July 10, 2014, from liver disease diagnosed after recent heart surgery. He was 55 years old.
Fifteen Lane Powell attorneys have been named 2014 “Oregon Super Lawyers,” and another five attorneys have been named as “Oregon Rising Stars” by Super Lawyers magazine.
From its first-ever member forum, to upcoming Board elections, the Oregon-based, non-profit health organization is focused on letting members control their healthcare destiny.